Cholangiocarcinoma: all 930 studies
Page 3 of 10. Open to participants first (292), then studies with results posted, then the rest; newest registration first within each.
- LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA)RecruitingNCT06098547Not applicable
- Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct AdenocarcinomaRecruitingNCT06092645Phase 2
- A Study to Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic TumorsRecruitingNCT06081322Phase 1
- Modified vs Conventional Blumgart Anastomosis of LPD for the Effects of Pancreatic Fistula of Periampullary CarcinomaEnrolling by invitationNCT06076252Not applicable
- Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic CholangiocarcinomaRecruitingNCT06058663Phase 1
- Prospective Observational Study to Predict the Response of Biliary Tract Tumors to ImmunotherapyRecruitingNCT06048289
- A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid TumorsRecruitingNCT06043466Phase 1
- CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for RecurrenceRecruitingNCT06037980Phase 2/3
- Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICCNot yet recruitingNCT06033118Phase 1/2
- A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)RecruitingNCT06028724
- Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid TumorsRecruitingNCT06010862Phase 1
- Cadonilimab With Chemotherapy in Treating Advanced Biliary CancerRecruitingNCT05978609Phase 2
- A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic CholangiocarcinomaRecruitingNCT05967182Phase 2
- [68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct CancerRecruitingNCT05957250Not applicable
- Combined Treatment of Treated Bile Duct CancerNot yet recruitingNCT05911425Phase 2
- The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract DiseasesNot yet recruitingNCT05896956
- Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated CholangiocarcinomaRecruitingNCT05874414Phase 1/2
- Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90)RecruitingNCT05872867Phase 1
- Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free)RecruitingNCT05835245Phase 2
- Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced CholangiocarcinomaRecruitingNCT05823311Phase 3
- Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic CholangiocarcinomaRecruitingNCT05738057Phase 2
- Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsRecruitingNCT05732831Phase 1/2
- Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or RearrangementRecruitingNCT05727176Phase 2
- FGF19 in Obstructive Cholestasis: "Unveil the Signal"RecruitingNCT05718349
- Liver Embolization Approaches for Tumor ManagementRecruitingNCT05714124
- Looking At Bile Duct Cancer Patient Experience Patterns in Medical TrialsNot yet recruitingNCT05706974
- Evaluation of the Patient's Experience in Medical Studies for CholangiocarcinomaNot yet recruitingNCT05694845
- Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor BoardsNot yet recruitingNCT05681949Not applicable
- A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic CholangiocarcinomaRecruitingNCT05678270Phase 2
- Clinical Feasibility of Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in Locally Advanced CholangiocarcinomaRecruitingNCT05677217
- Durvalumab Combined With GemCis Neoadjuvant Therapy of Resectable Intrahepatic Cholangiocarcinoma With High Recurrence RiskRecruitingNCT05672537Phase 2
- Y-90 With Durvalumab/Gem/Cis in Intrahepatic CholangioRecruitingNCT05655949Phase 2
- Advanced or Metastatic CholangiocarcinomaNot yet recruitingNCT05653817Not applicable
- Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic CholangiocarcinomaNot yet recruitingNCT05644743
- Screening Single-operator Cholangioscopy for Neoplastic Bile Duct LesionsRecruitingNCT05600803
- EUS-guided Choledochoduodenostomy for Primary Drainage of Malignant Distal Biliary ObstructionRecruitingNCT05595122Not applicable
- GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of RecurrenceRecruitingNCT05557578Phase 2
- Treatment of Non-resectable Bile Duct Cancer with Radiofrequency Ablation or Photodynamic TherapyRecruitingNCT05551299Phase 4
- Second Line Therapy for Advanced Intrahepatic CholangiocarcinomaNot yet recruitingNCT05535647Phase 2
- Lenvatinib, Tislelizumab Plus Gemcitabine and Cisplatin (GPLET) in Patients with Advanced CholangiocarcinomaRecruitingNCT05532059Phase 2
- Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic CholangiocarcinomaRecruitingNCT05519319Not applicable
- A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsRecruitingNCT05503797Phase 2
- Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic CancersRecruitingNCT05497531Not applicable
- Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)RecruitingNCT05451043Phase 2
- The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control CancerRecruitingNCT05422690Phase 2
- Analysis of the Incidence of Cholangiocarcinoma on Choledochal Cyst in a Western CenterEnrolling by invitationNCT05404503
- Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III StudyRecruitingNCT05342194Phase 3
- Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, ThailandRecruitingNCT05321992Not applicable
- PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical CarcinomaRecruitingNCT05286814Phase 2
- Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal MetastasesRecruitingNCT05285358Phase 1
- Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic CholangiocarcinomaEnrolling by invitationNCT05233293Not applicable
- An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic CholangiocarcinomaRecruitingNCT05223816Phase 2
- GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced CholangiocarcinomaRecruitingNCT05215665Not applicable
- Registry for Advanced EndoscopyRecruitingNCT05187312
- Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder CancerRecruitingNCT05184400
- Molecular Epidemiology of Biliary Tree CancersRecruitingNCT05179486
- A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsRecruitingNCT05150691Phase 1/2
- Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic CholangiocarcinomaRecruitingNCT05124002Phase 4
- Efficacy and Safety of 3D185 Monotherapy in Subjects With Previously Treated Locally Advanced or Metastatic CholangiocarcinomaNot yet recruitingNCT05039892Phase 2
- Lenvatinib Plus Sintilimab in Patients with Immune Checkpoint Inhibitor Previously Treated Advanced Liver CancerRecruitingNCT05010681Phase 2
- HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICCRecruitingNCT04961970Phase 3
- TACE Combined with Tislelizumab in Patients with Advanced Intrahepatic CholangiocarcinomaRecruitingNCT04954781Phase 2
- Deep Liver Phenotyping and Immunology StudyRecruitingNCT04946773
- Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With SurgeryRecruitingNCT04891289Phase 2
- Neoadjuvant PDT in the Treatment of CholangiocarcinomaNot yet recruitingNCT04824742Not applicable
- A Phase I Study of WM-S1-030 in Patients With Advanced Solid TumorsRecruitingNCT04801095Phase 1
- Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition SyndromeRecruitingNCT04792463
- Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC PatientsRecruitingNCT04753996
- Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract CancersRecruitingNCT04645160Phase 1/2
- Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesAvailableNCT04566393
- Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial)RecruitingNCT04556214Not applicable
- TCF-001 TRACK (Target Rare Cancer Knowledge) StudyRecruitingNCT04504604Not applicable
- Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II StudyRecruitingNCT04454905Phase 2
- Hepatobiliary Tumors Tissue Samples AcquisitionRecruitingNCT04445532
- BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid TumoursRecruitingNCT04421820Phase 1/2
- Cohort of Patients With Hepatocellular Carcinoma or CholangiocarcinomaRecruitingNCT04340986
- Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic CholangiocarcinomaRecruitingNCT04299581Phase 2
- AZD6738 Plus Durvalumab in Biliary Tract CancerRecruitingNCT04298008Phase 2
- Liver Transplant for Stable, Advanced Intrahepatic CholangiocarcinomaEnrolling by invitationNCT04195503Not applicable
- Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid MalignanciesRecruitingNCT04149691Phase 1
- Regional or Extend LymphAdenectomy During Resection of Intrahepatic CholangiocarcinomaRecruitingNCT04078230Not applicable
- Efficacy of Fistulotomy for Biliary CannulationRecruitingNCT04037007Not applicable
- Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver CancerRecruitingNCT03942328Phase 1/2
- Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma PatientsRecruitingNCT03924466Phase 2
- Intravital Microscopy in Human Solid TumorsRecruitingNCT03823144Not applicable
- Clinical Trial of Autologous Tcm Immunotherapy in ICCRecruitingNCT03820310Phase 2
- The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder CancerRecruitingNCT03637569
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- Biobank for Cholestatic Liver Diseases.RecruitingNCT03445585
- Chemo Alone or in Combination With Radiation in Unresectable CholangiocarcinomaRecruitingNCT02773485Phase 3
- Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of CancerRecruitingNCT01915225
- The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK CellsEnrolling by invitationNCT01868490Phase 1/2
- A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsCompletedNCT05712356Phase 2Results posted
- Study of [18F]FAPI-74 PET in Patients With Gastrointestinal CancersCompletedNCT05641896Phase 2Results posted
- A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerTerminatedNCT05451849Phase 1/2Results posted
- Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization TreatmentCompletedNCT05328167Phase 2Results posted
- Role of Proton Pump Inhibitors on the Postoperative Course Following PancreaticoduodenectomyTerminatedNCT05251233Phase 2Results posted
- Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsTerminatedNCT05194735Phase 1/2Results posted
- Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal CarcinomatosisCompletedNCT05185947Phase 2Results posted
- Milademetan in Advanced/Metastatic Solid TumorsTerminatedNCT05012397Phase 2Results posted